
References:
1.
El Amin EO. Issues in the management of scorpion
sting in children. Toxicon. 1992; 40: 111-115.
2.
Gueron M, Stern J and Cohen W. Severe myocardial
damage and heart failure in scorpion sting. Am.
J. Cardiology. 1967; 19: 719-25.
3.
Gueron M, Ilia R and Sofer S. The cardiovascular
system after scorpion envenomation: A review.
J. Toxicol. Clin. Toxicol. 1992; 30: 245-58.
4.
Bawaskar HS and Bawaskar PH. Treatment of cardiovas-
cular manifestations of human scorpion envenoming:
Is serotherapy essential? J trop Med Hygeine.
1992: 94:156-8.
5.
Kankonkar RC, Radhakrishna Murthy K, Zare AM,
Malathy A, Balasubramanian P. and Yeolekar ME.
Reversal of cardiovas- cular and haemodynamic
disturbances by scorpion antivenin administration
in myocarditis due to envenomation by Indian red
scorpion (buthidae family) venom. In: Abstracts
10th World Congress on animal, plants and microbial
toxins.Toxicon 1992; 30: 523.
6.
Ismail M, Fatani AJY and DabeesT. Experimental
treatment protocols for scorpion envenomation:
A review of common therapies and an effect of
kalkerin-kinin inhibitors. Toxicon. 1992: 30:
1257-79.
7.
Freire-Maia L, Almeid HO, Cunha-Melo JR, Azevedo
AD and Barroso J. Mechanism of the pulmonary oedema
induced by intravenous injection of scorpion toxin
in the rat. Agenus Actions. 1978; 8: 113-8.
8.
Goyffon M, Vashon M and Broglion N. Epidemiological
and clinical characteristics of the scorpion envenomation
in Tunisia. Toxicon. 1982: 20: 337-344.
9.
Ismail M, Shibli AM, Murad AM and Abdulla ME.
Pharmaco- kienetics of I-labled venom from the
scorpion androctonus amoreuxi (Aud &Sav).
Toxicon. 1980; 18: 301-8.
10.
Gueron M and Yaron R. Cardiovascular manifestations
of severe scorpion sting: Clinicopathological
correlations. Chest. 1970; 57: 156-62.
11.
Hering SE, Jurica M, Vichi FL, Azedovedo-Marques
MM and Cupo P. Reversible cardiomyopathy in patients
with severe scorpion envenoming by Titus serrulatus:
evolution of enzymatic, electrocardiographic alterations.
Annals of Tropical Pediatrics. 1993; 13: 173-182.
12.
Corrado APA, Ricciopo F and Anonio A. The mechanism
of the hypertensive effect of Brazilian scorpion
venom (Titus serrulatus, Luts & Mello). Toxicon.
1974; 12: 145-50.
13.
Freire-Maia L and Ferreira MC. Estudo do mecanismo
da hyperglicemia e da hypertensao arterial, produzidas
pelo veneno de escorpiao, no cao ( Abstract in
English). Mem Inst. Oswaldo Cruz. 1961; 59: 11-22.
14.
La Grnge RG. Elevation of blood pressure and plasma
renin levels by venom from scorpions, Centruroides
sculpturatus and leiurus quinquestriatus. Toxicon.
1977; 15: 429-33.
15.
Nascimento EP, Azedovido AD and Freire-Maia L.
Velosidade de elevacao da pressao arterialsistemica,
induzida pela Tityus toxina,como fator na genese
de edema pulmonar em ratos nao anesteziados (English
Abstract). In: 1 Reuniao Annual da Federaccao
das Sociedades de Biologica Experimental. p158.
16.
Freire-Maia L, Pinto GI and Franco I. Mechanism
of the cardiovascular effects produced by purified
scorpion toxin in the rat. J Pharmac & Ther.
1974; 188: 207.
17.
Gueron M, Margulis G and Sofer S. Echocardiographic
and radionucleide angiographic observations following
scorpion envenomation by Leiurus quinquestriatus.
Toxicon. 1990; 28: 1005-9.
18.
Savino ED and Catanzaro OL. The effects of Titus
toxin on the isolated rat portal vein. IRCS: Med.
Science. 1979; 7; 317.
19.
Olivera Antonio MP, Fernandes F, Goncalves Jr.
and Rocha e Silva M. Pharmacological analysis
of the mediators involved in the acute pulmonary
oedema produced in rats by adrenalin. Agents Actions.
1973; 3: 383.
20.
Sofer S and Gueron M. Respiratory failure in children
following envenomation by the scorpion Leiurus
quenques- triatus: Hemodynamics and neurological
aspects. Toxicon. 1988; 26; 931-9.
21.
Elamin EO, Miraj-Uldin K. Hematological and biochemical
findings in scorpion stung children. Annals of
Saudi Medicine. 1991; 11: 625-7.
22.
Ismail M, Gumaa KA, Osman H and El Asmar MF. Effects
of Buthus minax (L Koch) scorpion venom on plasma
and urinary electrolyte levels. Toxicon. 1978;
16: 385-92.
23.
Devi CS, Reddy SL, Subramaniam YR, Batt HV, Suvarankumari
G, Murthy DP and Reddy CR. Defibrination syndrome
due to scorpion venom poisoning. Br Med J 1970;
1: 345-7.
24.
El Amin EO, Elidrissy A, Hamid HS, Sultan OM and
Safar RA. Scorpion sting: A management problem.
Annals of Tropical Pediatrics. 1991; 11: 143-8.
25.
Gueron M and Ovsyshcher I. What is the treatment
for the cardiovascular manifestations of scorpion
envenomation. Toxicon. 1986; 25: 121-4.
26.
Freire-Maia L, Campos JA. Response to the letter
to the editor by Gueron and Ovsyshcher on the
treatment of the cardiovas- cular manifestations
of scorpion envenomation. Toxicon. 1987; 25: 125-30.
27.
El Amin EO, Sultan OM, Al Magamci MS and Elidrissy
A. Serotherapy in the management of scorpion sting
in children in Saudi Arabia. Annals of Tropical
Pediatrics.
28.
Gueron M, Margulis G, Illia R and Sofer S. The
management of scorpion envenomation. Toxicon.
1993; 31: 1071-6.
29.
Ismail M. Serotherapy of the scorpion envenoming
syndrome is irrationally convicted without trial.
Toxicon. 1993; 31: 1077-83.
30.
Pasteur Vaccines. Pasteur Laboratories, 1 Bd Raymond
PO Incarre, BP 10-92430, Marnes La Conquette,
France.
31.
Karnad DR, Avinash MD, Nitin Ashutosh S, Sunil
T and Tilve GH. Captopril for correcting diuretic
induced hypoten- sion in pulmonary oedema after
scorpion sting. Br Med J; 1989: 1430-1.